Prognostic value of 18F-fluoroethyl-L-tyrosine PET and MRI in small nonspecific incidental brain lesions

Journal of Nuclear Medicine

Volumn 49, Issue 5, 2008, Pages 730-737

  Floeth, Frank Willi ^a   Sabel, Michael ^a   Stoffels, Gabriele ^b,c   Pauleit, Dirk ^b,c   Hamacher, Kurt ^b,c   Steiger, Hans Jakob ^a   Langen, Karl Josef ^b,c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

^c Brain Imaging Center West   (Germany)

Author keywords

18F fluoroethyl L tyrosine; Incidental finding; MRI; Nonspecific brain lesions; PET; Prognosis

Indexed keywords

FLUOROETHYL TYROSINE F 18; RADIOPHARMACEUTICAL AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; O (2 FLUOROETHYL)TYROSINE; O-(2-FLUOROETHYL)TYROSINE; TYROSINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN DAMAGE; CANCER GRADING; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIZZINESS; FEMALE; FOLLOW UP; HEADACHE; HUMAN; ISOTOPE LABELING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SUDDEN DEAFNESS; SYMPTOM; WORLD HEALTH ORGANIZATION; BRAIN; DISEASE COURSE; GLIOMA; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; BRAIN; CHILD; DISEASE PROGRESSION; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; TYROSINE;

EID: 44149114514     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.050005     Document Type: Article

References (39)

1. Weber F, Knopf H. Incidental findings in magnetic resonance imaging of the brains of healthy young men. J Neurol Sci. 2006;240:81-84.
2. Eskandary H, Sabba M, Khajehpour F, Eskandari M. Incidental findings in brain computed tomography scans of 3000 head trauma patients. Surg Neurol. 2005;63:50-53.
3. Kim BS, Illes J, Kaplan RT, Reiss A, Atlas SW. Incidental findings on pediatric MR images of the brain. Am J Neuroradiol. 2002;23:1674-1677.
4. Onizuka M, Suyama K, Shibayama A, et al. Asymptomatic brain tumor detected at brain check-up. Neurol Med Chir (Tokyo). 2001;41:431-434.
5. Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA. 1999;282:36-39.
6. 18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma. J Nucl Med. 2007;48:519-527.
7. Burzynski SR. Treatments for astrocytic tumors in children: current and emerging strategies. Paediatr Drugs. 2006;8:167-178.
8. Pollack IF, Shultz BBS, Mulvihill JJ. The management of brainstem gliomas in patients with neurofibromatosis. Neurology. 1996;46:1652-1660.
9. 18F-FET PET differentiation of ring-enhancing brain lesions. J Nucl Med. 2006;47:776-782.
10. 18F] Fluoroethyl)-L-tyrosine PET combined with magnetic resonance imaging improves the diagnostic assessment of cerebral gliomas. Brain. 2005;128:678-687.
11. 18F] fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. J Neurosurg. 2005;102:318-327.
12. Messing-Jünger AM, Floeth FW, Pauleit D, et al. Multimodal target point assessment for stereotactic biopsy in children with diffuse bithalamic astrocytomas. Childs Nerv Syst. 2002;18:445-449.
13. 18F]fluoroethyl)-L-tyrosine. Appl Radiat Isot. 2002;57:853-856.
14. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215-225.
15. Steiger HJ. Preventive neurosurgery: population-wide check-up examinations and correction of asymptomatic pathologies of the nervous system. Acta Neurochir (Wien). 2006;148:1075-1083.
16. Illes J. 'Pandora's box' of incidental findings in brain imaging research. Nat Clin Pract Neurol. 2006;2:60-61.
17. Mamourian A. Incidental findings on research functional MR images: should we look? AJNR. 2004;25:520-522.
18. Illes J, Rosen AC, Huang L, et al. Ethical consideration of incidental findings on adult brain MRI in research. Neurology. 2004;62:888-890.
19. Illes J, Kirschen MP, Karetsky K, et al. Discovery and disclosure of incidental findings in neuroimaging research. J Magn Reson Imaging. 2004;20:743-747.
20. How volunteering for an MRI scan changed my life [letter]. Nature. 2005;434:17.
21. Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer. 2006;106:1358-1363.
22. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64:479-489.
23. Whittle IR. The dilemma of low grade glioma. J Neurol Neurosurg Psychiatry. 2004;75(suppl 2):31-36.
24. Mandonnet E, Delattre JY, Tanguy ML, et al. Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol. 2003;53:524-528.
25. Wessels PH, Weber WE, Raven G, et al. Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol. 2003;2:395-403.
26. Keles GE, Lamborn KR, Berger MS. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg. 2001;95:735-745.
27. Kreth FW, Faist M, Rossner R, Volk B, Ostertag CB. Supratentorial World Health Organization grade 2 astrocytomas and oligoastrocytomas: a new pattern of prognostic factors. Cancer. 1997;79:370-379.
28. Piepmeier J, Christopher S, Spencer D, et al. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery. 1996;38:872-878.
29. Kreth FW, Faist M, Warnke PC, et al. Interstitial radiosurgery of low-grade gliomas. J Neurosurg. 1995;82:418-429.
30. Janny P, Cure H, Mohr M, et al. Low grade supratentorial astrocytomas: management and prognostic factors. Cancer. 1994;73:1937-1945.
31. Philippon JH, Clemenceau SH, Fauchon FH, Foncin JF. Supratentorial low-grade astrocytomas in adults. Neurosurgery. 1993;32:554-559.
32. Shaw EG, Daumas-Duport C, Scheithauer BW, et al. Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg. 1989;70:853-861.
33. Laws ER Jr, Taylor WF, Clifton MB, Okazaki H. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg. 1984;61:665-673.
34. Herholz K, Holzer T, Bauer B, et al. 11C-Methionine PET for differential diagnosis of low-grade gliomas. Neurology. 1998;50:1316-1322.
35. 11C-methionine and survival in patients with low-grade gliomas. Cancer. 2001;92:1541-1549.
36. 18F] Fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol. 2006;33:287-294.
37. 18F-fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med. 1999;40:205-212.
38. 18F]fluoroethyl)-L-tyrosine PET in the evaluation of primary brain tumors. Eur J Nucl Med. 2005;32:422-429.
39. 18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging. 2004;31:1464-1470.